While we understand the desire for a label or “official” diagnosis, it makes me scratch my head (no pun intended) that providers offer scalp biopsies because while they claim that they’ll help to determine an “accurate diagnosis,” they rarely change their treatment plan based on the results.
Posted by Jill McLaughlin (Grunewald) on Jul 23, 2022
Posted by Jill McLaughlin (Grunewald) on Jul 14, 2022
The FDA just approved the sixth iteration of JAK (Janus kinase) inhibitors for alopecia. But just because it’s newly approved doesn’t mean it’s great because none of the JAK inhibitors are great. In fact, the FDA has also issued a black box warning.